{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T21:36:26Z","timestamp":1786484186331,"version":"build-2736575974"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background\/Purpose<\/jats:title><jats:p>Primary Sj\u00f6gren\u2019s Syndrome (SS) is characterized by B lymphocyte hyperactivity with B cell activating factor (BAFF) acting as an important regulator. Single Nucleotide Polymorphisms (SNPs) of the <jats:italic>BAFF<\/jats:italic> gene have been implicated in the pathogenesis of several autoimmune diseases characterized by heightened fatigue levels, including primary SS. We aimed to explore potential associations between <jats:italic>BAFF<\/jats:italic> SNPs and fatigue status of primary SS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Fatigue status was assessed in 199 consecutive primary SS patients (Greek cohort) using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scale. Clinical, histological, laboratory, psychometric and personality data were also collected. DNA extracted from peripheral blood of all patients underwent evaluation for the presence of five <jats:italic>BAFF<\/jats:italic> SNPs (rs9514827, rs1041569, rs9514828, rs1224141, rs12583006) by PCR. To confirm our findings, an independent replicative cohort of 62 primary SS patients (Dutch cohort) was implemented. Finally, 52 multiple sclerosis (MS) patients were served as disease controls (MS cohort). Analysis of <jats:italic>BAFF<\/jats:italic> SNPs in association with fatigue levels was performed by the online platforms SNPStats and SHEsis and the SPSS 26 and Graph Pad Prism 8.00 software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>TT genotype of the rs9514828 <jats:italic>BAFF<\/jats:italic> polymorphism was significantly less frequent in the fatigued primary SS patients of the Greek cohort compared to the non-fatigued (14.1% vs 33.3%). The corresponding ORs [95%CI] in the dominant and overdominant models were 0.33 [0.15-0.72], p=0.003 and 0.42 [0.23-0.78], p=0.005 respectively. The association remained significant after adjustment for the variables contributing to fatigue in the univariate analysis (OR [95% CI]: 0.3 [0.1-0.9], p=0.026). Accordingly, in the Dutch cohort, there was a trend of lower mental fatigue among patients carrying the TT rs9514828 <jats:italic>BAFF<\/jats:italic> genotype compared to their CC counterparts (4.1 \u00b1 2.4 vs 6.0 \u00b1 2.2 respectively, p=0.06). The rs9514828 <jats:italic>BAFF<\/jats:italic> SNP was not significantly associated with fatigue in the MS cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We report a novel association between genetic makeup and primary SS-associated fatigue with the rs9514828 TT genotype decreasing the likelihood of\u00a0fatigue development among these patients. These findings need validation in multi-center studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.836824","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T04:51:16Z","timestamp":1647319876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Christina-Maria","family":"Flessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Zampeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Eleftheria","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Natsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris L. A.","family":"Bodewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Huijser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan A.","family":"Versnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos M.","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.11.004","article-title":"The Geoepidemiology of Sjogren's Syndrome","volume":"9","author":"Mavragani","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0165","article-title":"The Management of Sjogren's Syndrome","volume":"2","author":"Mavragani","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22263","article-title":"Primary Sjogren's Syndrome: Fatigue Is an Ever-Present, Fluctuating, and Uncontrollable Lack of Energy","volume":"66","author":"Mengshoel","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21738","article-title":"Impaired Functional Status in Primary Sjogren's Syndrome","volume":"64","author":"Hackett","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): Development of a Consensus Patient Index for Primary Sjogren's Syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22720","article-title":"Fatigue in Primary Sjogren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations","volume":"68","author":"Karageorgas","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B7","article-title":"Fatigue and Widespread Pain in Systemic Lupus Erythematosus and Sjogren's Syndrome: Symptoms of the Inflammatory Disease or Associated Fibromyalgia","volume":"30","author":"Iannuccelli","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.24311","article-title":"Prevalence, Severity, and Predictors of Fatigue in Subjects With Primary Sjogren's Syndrome","volume":"59","author":"Segal","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.rdc.2008.08.010","article-title":"Patient-Reported Outcomes Including Fatigue in Primary Sjogren's Syndrome","volume":"34","author":"Bowman","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq009","article-title":"Primary Sjogren's Syndrome: Too Dry and Too Tired","volume":"49","author":"Ng","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.221","article-title":"Chronic Fatigue Syndrome: A Review","volume":"160","author":"Afari","year":"2003","journal-title":"Am J Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/S0317167100048691","article-title":"The Impact of Fatigue on Patients With Multiple Sclerosis","volume":"21","author":"Fisk","year":"1994","journal-title":"Can J Neurol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1477-7525-6-100","article-title":"North American Research Committee on Multiple S. Fatigue Characteristics in Multiple Sclerosis: The North American Research Committee on Multiple Sclerosis (NARCOMS) Survey","volume":"6","author":"Hadjimichael","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2017.1247695","article-title":"Pathophysiology, Assessment and Management of Multiple Sclerosis Fatigue: An Update","volume":"17","author":"Rottoli","year":"2017","journal-title":"Expert Rev Neurother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00692-1","article-title":"Fatigue in Inflammatory Rheumatic Diseases: Current Knowledge and Areas for Future Research","volume":"17","author":"Davies","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/OARRR.S167990","article-title":"Managing Fatigue in Patients With Primary Sjogren's Syndrome: Challenges and Solutions","volume":"11","author":"Miyamoto","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq023","article-title":"Sleepiness or Fatigue? Can We Detect Treatable Causes of Tiredness in Primary Sjogren's Syndrome","volume":"49","author":"Theander","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/0308022617745006","article-title":"Experience of Sleep Disruption in Primary Sjogren's Syndrome: A Focus Group Study","volume":"81","author":"Hackett","year":"2018","journal-title":"Br J Occup Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000885","article-title":"Pain and Depression Are Associated With Both Physical and Mental Fatigue Independently of Comorbidities and Medications in Primary Sjogren's Syndrome","volume":"5","author":"Hackett","year":"2019","journal-title":"RMD Open"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/03009740801907995","article-title":"Fatigue and Blood Pressure in Primary Sjogren's Syndrome","volume":"37","author":"d'Elia","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.219","article-title":"Autonomic Dysfunction in Primary Sjogren's Syndrome: A Prospective Cohort Analysis of 154 Korean Patients","volume":"32","author":"Koh","year":"2017","journal-title":"Korean J Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000282","article-title":"Fatigue in Primary Sjogren's Syndrome Is Associated With Lower Levels of Proinflammatory Cytokines","volume":"2","author":"Howard Tripp","year":"2016","journal-title":"RMD Open"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202863","article-title":"Health-Related Utility Values of Patients With Primary Sjogren's Syndrome and Its Predictors","volume":"73","author":"Lendrem","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12888-018-1715-x","article-title":"Anxiety and Depression in Primary Sjogren's Syndrome: A Cross-Sectional Study","volume":"18","author":"Cui","year":"2018","journal-title":"BMC Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/ard.61.3.284","article-title":"Fatigue and Immune Activity in Sjogren's Syndrome","volume":"61","author":"Bax","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu387","article-title":"Psychological Profiles in Patients With Sjogren's Syndrome Related to Fatigue: A Cluster Analysis","volume":"54","author":"van Leeuwen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/03009742.2016.1153142","article-title":"Pain, Xerostomia, and Younger Age Are Major Determinants of Fatigue in Korean Patients With Primary Sjogren's Syndrome: A Cohort Study","volume":"46","author":"Koh","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3035-6","article-title":"The Prevalence of Severe Fatigue in Rheumatic Diseases: An International Study","volume":"35","author":"Overman","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/1753425916633236","article-title":"Heat Shock Proteins and Chronic Fatigue in Primary Sjogren's Syndrome","volume":"22","author":"Bardsen","year":"2016","journal-title":"Innate Immun"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143970","article-title":"A Transcriptional Signature of Fatigue Derived From Patients With Primary Sjogren's Syndrome","volume":"10","author":"James","year":"2015","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00312","article-title":"Fatigue in Sjogren's Syndrome: A Search for Biomarkers and Treatment Targets","volume":"10","author":"Bodewes","year":"2019","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2050312119850390","DOI":"10.1177\/2050312119850390","article-title":"Fatigue in Primary Sjogren's Syndrome: A Proteomic Pilot Study of Cerebrospinal Fluid","volume":"7","author":"Larssen","year":"2019","journal-title":"SAGE Open Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and Safety of Belimumab in Primary Sjogren's Syndrome: Results of the BELISS Open-Label Phase II Study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev257","article-title":"Efficacy and Safety of Belimumab Given for 12 Months in Primary Sjogren's Syndrome: The BELISS Open-Label Phase II Study","volume":"54","author":"De Vita","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23788","article-title":"Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment","volume":"71","author":"Strand","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23718","article-title":"The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus","volume":"71","author":"Parodis","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.651249","article-title":"Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus","volume":"8","author":"Gomez","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-00789-9","article-title":"Exploring the Association Between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study","volume":"42","author":"Minnema","year":"2019","journal-title":"Drug Saf"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312469259","article-title":"Safety Profile of Belimumab: Pooled Data From Placebo-Controlled Phase 2 and 3 Studies in Patients With Systemic Lupus Erythematosus","volume":"22","author":"Wallace","year":"2013","journal-title":"Lupus"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(89)90180-7","article-title":"Personality Structure Disturbances and Psychiatric Manifestations in Primary Sjogren's Syndrome","volume":"2","author":"Drosos","year":"1989","journal-title":"J Autoimmun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2013.04.005","article-title":"B-Cell Activating Factor Genetic Variants in Lymphomagenesis Associated With Primary Sjogren's Syndrome","volume":"51","author":"Nezos","year":"2014","journal-title":"J Autoimmun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken246","article-title":"Polymorphism in the 5' Regulatory Region of the B-Lymphocyte Activating Factor Gene Is Associated With the Ro\/La Autoantibody Response and Serum BAFF Levels in Primary Sjogren's Syndrome","volume":"47","author":"Nossent","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610528","article-title":"Overexpression of the Cytokine BAFF and Autoimmunity Risk","volume":"376","author":"Steri","year":"2017","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sjogren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren's Syndrome Disease Activity Index: Development of a Consensus Systemic Disease Activity Index for Primary Sjogren's Syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating Neurologic Impairment in Multiple Sclerosis: An Expanded Disability Status Scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"B48","volume-title":"Manual for the State-Trait Anxiety, Inventory","author":"Spielberger","year":"1970"},{"key":"B49","volume-title":"Manual of the Eysenck Personality Questionnaire (Junior & Adult)","author":"Eysenck","year":"1975"},{"key":"B50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","article-title":"A Self-Rating Depression Scale","volume":"12","author":"Zung","year":"1965","journal-title":"Arch Gen Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(00)00095-7","article-title":"Athens Insomnia Scale: Validation of an Instrument Based on ICD-10 Criteria","volume":"48","author":"Soldatos","year":"2000","journal-title":"J Psychosom Res"},{"key":"B52","volume-title":"Psychometric Tools in Greece","author":"Stalikas","year":"2002"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10245","article-title":"Fatigue in Cancer Patients Compared With Fatigue in the General United States Population","volume":"94","author":"Cella","year":"2002","journal-title":"Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.03.013","article-title":"General Population Norms for the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale","volume":"21","author":"Montan","year":"2018","journal-title":"Value Health"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20577","article-title":"Measures of Psoriatic Arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI)","author":"Mease","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S124886","article-title":"Evaluation of Fatigue and Its Correlation With Quality of Life Index, Anxiety Symptoms, Depression and Activity of Disease in Patients With Psoriatic Arthritis","volume":"10","author":"Carneiro","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04871.x","article-title":"Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) in Patients With Inflammatory Bowel Disease","volume":"34","author":"Tinsley","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"B58","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/ar3487","article-title":"A Five-Year Prospective Study of Fatigue in Primary Sjogren's Syndrome","volume":"13","author":"Haldorsen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B59","article-title":"Increased Severity of Lower Urinary Tract Symptoms and Daytime Somnolence in Primary Sjogren's Syndrome","volume":"30","author":"Walker","year":"2003","journal-title":"J Rheumatol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7525-7-46","article-title":"Primary Sjogren's Syndrome: Health Experiences and Predictors of Health Quality Among Patients in the United States","volume":"7","author":"Segal","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/art.41489","article-title":"Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjogren's Syndrome: A Randomized Clinical Trial","volume":"73","author":"Posada","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199783106.001.0001","volume-title":"Rating Scales in Parkinson's Disease: Clinical Practice and Research","author":"Sampaio","year":"2012"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) Psychometric Qualities of an Instrument to Assess Fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J Psychosom Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh170","article-title":"Measurement of Fatigue and Discomfort in Primary Sjogren's Syndrome Using a New Questionnaire Tool","volume":"43","author":"Bowman","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206008","article-title":"Defining Disease Activity States and Clinically Meaningful Improvement in Primary Sjogren's Syndrome With EULAR Primary Sjogren's Syndrome Disease Activity (ESSDAI) and Patient-Reported Indexes (ESSPRI)","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The Fatigue Severity Scale. Application to Patients With Multiple Sclerosis and Systemic Lupus Erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509348519","article-title":"The Fatigue Scale for Motor and Cognitive Functions (FSMC): Validation of a New Instrument to Assess Multiple Sclerosis-Related Fatigue","volume":"15","author":"Penner","year":"2009","journal-title":"Mult Scler"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1080\/14034940410028406","article-title":"Fatigue in the General Population: A Translation and Test of the Psychometric Properties of the Norwegian Version of the Fatigue Severity Scale","volume":"33","author":"Lerdal","year":"2005","journal-title":"Scand J Public Health"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: A Web Tool for the Analysis of Association Studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.33","article-title":"A Partition-Ligation-Combination-Subdivision EM Algorithm for Haplotype Inference With Multiallelic Markers: Update of the SHEsis (http:\/\/Analysis.bio-x.cn)","volume":"19","author":"Li","year":"2009","journal-title":"Cell Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290272","article-title":"SHEsis, a Powerful Software Platform for Analyses of Linkage Disequilibrium, Haplotype Construction, and Genetic Association at Polymorphism Loci","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar1884","article-title":"No Evidence for an Association Between the -871 T\/C Promoter Polymorphism in the B-Cell-Activating Factor Gene and Primary Sjogren's Syndrome","volume":"8","author":"Gottenberg","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B73","first-page":"198","article-title":"Phenotyping Sjogren's Syndrome: Towards a Personalised Management of the Disease","author":"Brito-Zeron","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early Diagnosis of Primary Sjogren's Syndrome: EULAR-SS Task Force Clinical Recommendations","volume":"12","author":"Brito-Zeron","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04354-0","article-title":"Fatigue in Primary Sjogren's Syndrome (pSS) Is Associated With Lower Levels of Proinflammatory Cytokines: A Validation Study","volume":"39","author":"Davies","year":"2019","journal-title":"Rheumatol Int"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703079","article-title":"Understanding Fatigue in Sjogren's Syndrome: Outcome Measures, Biomarkers and Possible Interventions","volume":"12","author":"Maeland","year":"2021","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22974","article-title":"Severe Health-Related Quality of Life Impairment in Active Primary Sjogren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial","volume":"69","author":"Cornec","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s42358-021-00181-9","article-title":"Pain and Fatigue Are Predictors of Quality of Life in Primary Sjogren's Syndrome","volume":"61","author":"Dias","year":"2021","journal-title":"Adv Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.09.010","article-title":"Ligands and Receptors of the TNF Superfamily Are Decreased in Major Depression and During Early Antidepressant Therapy","volume":"119","author":"Schmidt","year":"2019","journal-title":"J Psychiatr Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2010.04.003","article-title":"The Genetics and Epigenetics of Fatigue","volume":"2","author":"Landmark-Hoyvik","year":"2010","journal-title":"PM R"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.01.007","article-title":"A Systematic Review of the Association Between Fatigue and Genetic Polymorphisms","volume":"62","author":"Wang","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2850-9","article-title":"A Possible Genetic Association With Chronic Fatigue in Primary Sjogren's Syndrome: A Candidate Gene Study","volume":"34","author":"Norheim","year":"2014","journal-title":"Rheumatol Int"},{"key":"B83","article-title":"Genetic Determinants of Fatigue in Primary Sj\u00f6gren`s Syndrome \u2013 A Genome Wide Association Study [Abstract]","volume":"69","author":"Norheim","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001832","article-title":"Genetic Variants at the RTP4\/MASP1 Locus are Associated With Fatigue in Scandinavian Patients With Primary Sjogren's Syndrome","volume":"7","author":"Norheim","year":"2021","journal-title":"RMD Open"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew008","article-title":"Epigenome-Wide DNA Methylation Patterns Associated With Fatigue in Primary Sjogren's Syndrome","volume":"55","author":"Braekke Norheim","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"102802","DOI":"10.1016\/j.autrev.2021.102802","article-title":"The Relationship Between BAFF Serum Levels, Anti-NMDAR Autoantibodies and Fatigue in Patients With Systemic Lupus Erythematosus and Multiple Sclerosis","volume":"20","author":"Basta","year":"2021","journal-title":"Autoimmun Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.836824\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T04:51:26Z","timestamp":1647319886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.836824\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":86,"alternative-id":["10.3389\/fimmu.2022.836824"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.836824","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"article-number":"836824"}}